Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Contact Phone:
Contact Email:
Listed Exchange:
SSE
IPO Date:
8/24/1994
Ticker Symbol:
600867
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2015 | AMOYTOP BIOTECH | Funding Round | 7.7M |
4/2017 | POCTech Corporation | Series B | 14.5M |
4/2017 | POCTech Corporation | Series B | 0 |
12/2015 | AMOYTOP BIOTECH | Funding Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|